DYSLIPIDEMIA STATUS AND CARDIOVASCULAR RISK IN TYPE 2 DIABETES MELLITUS OUTPATIENTS TREATED AT BAC NINH PROVINCIAL ENDOCRINOLOGY HOSPITAL
Main Article Content
Abstract
Objective: This study aimed to describe the characteristics of dyslipidemia and cardiovascular risk in type 2 diabetes mellitus (T2DM) patients.
Methods: A cross-sectional descriptive study was conducted on 300 T2DM outpatients at the General Examination Department - Bac Ninh Provincial Endocrinology Hospital from September 2024 to September 2025. Key research variables included lipid profiles (Total Cholesterol, Triglycerides, HDL-C, LDL-C), HbA1c, and 10-year cardiovascular risk assessment using the Framingham Risk Score (FRS).
Results: The overall prevalence of dyslipidemia in the study group was 58.3%. The dyslipidemia phenotype was predominantly characterized by high total cholesterol (43.3%) and high triglycerides (32.7%). Notably, the prevalence of high LDL-C was very low (2.7%). Regarding cardiovascular risk, 10.0% of patients were stratified as high-risk and 33.3% as moderate-risk according to the FRS. For glycemic control, 71.0% of patients failed to achieve the target HbA1c < 7.0%. Analysis of associated factors identified that male gender (p=0.021) and concurrent dyslipidemia (p=0.033) were significantly associated with poorer HbA1c control compared to other groups.
Conclusion: The study demonstrates a high prevalence of dyslipidemia and poor glycemic control. Dyslipidemia (especially hypertriglyceridemia) and male gender are factors associated with failing to meet glycemic targets in this patient population.
Article Details
Keywords
Type 2 Diabetes, Dyslipidemia, Triglycerides, Cardiovascular Risk, HbA1c, Framingham.
References
2. Bộ Y tế (2022), Quyết định 2892/QĐ-BYT năm 2022 về việc ban hành tài liệu "Hướng dẫn chẩn đoán và điều trị bệnh béo phì", Bộ Y tế Việt Nam.
3. Vũ Thanh Giang, Chu Thị Hường và Nguyễn Thị Phương Thảo (2024), "Phân tầng nguy cơ tim mạch do rối loạn lipid máu ở bệnh nhân Đái tháo đường type 2 tại Bệnh viện Đa khoa tỉnh Bắc Giang", Tạp chí Y học Việt Nam, 542(1). https://doi.org/10.51298/vmj.v547i3.13165
4. Huỳnh Văn Minh và các cộng sự. (2022), Khuyến cáo chẩn đoán và điều trị tăng huyết áp - Hội Tim mạch học Quốc gia Việt Nam (Bản tóm tắt), Hội Tim mạch học Quốc gia Việt Nam.
5. Nguyễn Văn Tuấn và Phan Thị Hà Linh (2022), "Rối loạn lipid máu và nguy cơ tim mạch ở bệnh nhân đái tháo đường type 2", Tạp chí y học Việt Nam, 513(1), tr. 146-150. https://doi.org/10.51298/vmj.v513i1.2353
6. Nguyễn Quốc Thái (2024), Cập nhật chẩn đoán, điều trị và quản lý rối loạn Lipid máu, Viện Tim mạch Việt Nam - Bệnh viện Bạch Mai.
7. American Diabetes Association (2024), " Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes-2024", Diabetes Care, 47(Suppl 1), pp. S111-s125.
8. Framingham Heart Study (2023), Hard Coronary Heart Disease (10-Year Risk), ad web https://www.framinghamheartstudy.org/fhs-risk-functions/hard-coronary-heart-disease-10-year-risk/.
9. Magliano DJ and Boyko EJ (2021), IDF Diabetes Atlas, I. D. F. Diabetes Atlas Scientific Committee và Edition, ed, International Diabetes Federation, Brussels.
10. Wang L. and et al. (2021), "Predictive Value of the Triglyceride to High-Density Lipoprotein Cholesterol Ratio for All-Cause Mortality and Cardiovascular Death in Diabetic Patients With Coronary Artery Disease Treated With Statins", Front Cardiovasc Med, 8, pp. 718604. https://doi.org/10.3389/fcvm.2021.718604